Non-invasive quantification of tumour heterogeneity in water diffusivity to differentiate malignant from benign tissues of urinary bladder: a phase I study

European Radiology

Volumn 27, Issue 5, 2017, Pages 2146-2152

  Nguyen, Huyen T ^a   Shah, Zarine K ^a   Mortazavi, Amir ^a   Pohar, Kamal S ^a   Wei, Lai ^a   Jia, Guang ^b,c   Zynger, Debra L ^a   Knopp, Michael V ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

^c PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Apparent Diffusion Coefficient; Bladder malignancy; Histogram analysis; K means clustering; Tumour heterogeneity

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; WATER;

ADJUVANT THERAPY; ADULT; APPARENT DIFFUSION COEFFICIENT; ARTICLE; BLADDER CANCER; BLADDER TUMOR; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTECTOMY; DIFFUSION; ENTROPY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MIDDLE AGED; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; TUMOR DIFFERENTIATION; AGED; CANCER STAGING; CLINICAL TRIAL; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; URINARY BLADDER DISEASES; URINARY BLADDER NEOPLASMS;

AGED; CYSTECTOMY; DIAGNOSIS, DIFFERENTIAL; DIFFUSION; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NEOPLASM STAGING; REPRODUCIBILITY OF RESULTS; URINARY BLADDER DISEASES; URINARY BLADDER NEOPLASMS; WATER;

EID: 84983443493     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-016-4549-2     Document Type: Article

References (28)

1. Bhatt J, Cowan N, Protheroe A, Crew J (2012) Recent advances in urinary bladder cancer detection. Expert Rev Anticancer Ther 12:929–939
2. Sadow CA, Silverman SG, O'Leary MP, Signorovitch JE (2008) Bladder cancer detection with CT urography in an Academic Medical Center. Radiology 249:195–202
3. Setty BN, Holalkere NS, Sahani DV, Uppot RN, Harisinghani M, Blake MA (2007) State-of-the-art cross-sectional imaging in bladder cancer. Curr Probl Diagn Radiol 36:83–96
4. Shariat SF, Karam JA, Lotan Y, Karakiewizc PI (2008) Critical evaluation of urinary markers for bladder cancer detection and monitoring. Rev Urol 10:120–135
5. Tatsugami K, Kuroiwa K, Kamoto T, Nishiyama H, Watanabe J, Ishikawa S et al (2010) Evaluation of narrow-band imaging as a complementary method for the detection of bladder cancer. J Endourol / Endourol Soc 24:1807–1811
6. Nishimura K, Fujiyama C, Nakashima K, Satoh Y, Tokuda Y, Uozumi J (2009) The effects of neoadjuvant chemotherapy and chemo-radiation therapy on MRI staging in invasive bladder cancer: comparative study based on the pathological examination of whole layer bladder wall. Int Urol Nephrol 41:869–875
7. Lambregts DM, Lahaye MJ, Heijnen LA, Martens MH, Maas M, Beets GL, Beets-Tan RG (2016) MRI and diffusion-weighted MRI to diagnose a local tumour regrowth during long-term follow-up of rectal cancer patients treated with organ preservation after chemoradiotherapy. Eur Radiol 26(7):2118–2125
8. Wagner M, Ronot M, Doblas S, Giraudeau C, Van Beers B, Belghiti J et al (2016) Assessment of the residual tumour of colorectal liver metastases after chemotherapy: diffusion-weighted MR magnetic resonance imaging in the peripheral and entire tumour. Eur Radiol 26:206–215
9. Avcu S, Koseoglu MN, Ceylan K, Bulut MD, Unal O (2011) The value of diffusion-weighted MRI in the diagnosis of malignant and benign urinary bladder lesions. Br J Radiol 84:875–882
10. Davnall F, Yip CS, Ljungqvist G, Selmi M, Ng F, Sanghera B et al (2012) Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging 3:573–589
11. Just N (2014) Improving tumour heterogeneity MRI assessment with histograms. Br J Cancer 111:2205–2213
12. Alic L, Niessen WJ, Veenland JF (2014) Quantification of heterogeneity as a biomarker in tumor imaging: a systematic review. Plos One 9:e110300
13. Jerome NP, Miyazaki K, Collins DJ, Orton MR, d’Arcy JA, Wallace T et al (2016) Repeatability of derived parameters from histograms following non-Gaussian diffusion modelling of diffusion-weighted imaging in a paediatric oncological cohort. Eur Radiol. doi:10.1007/s00330-016-4318-2
14. Andersen EK, Kristensen GB, Lyng H, Malinen E (2011) Pharmacokinetic analysis and k-means clustering of DCEMR images for radiotherapy outcome prediction of advanced cervical cancers. Acta Oncol 50:859–865
15. Docquier PL, Paul L, Menten R, Cartiaux O, Francq B, Banse X (2009) Measurement of bone cyst fluid volume using k-means clustering. Magn Reson Imaging 27:1430–1439
16. Gray C, MacGillivray TJ, Eeley C, Stephens NA, Beggs I, Fearon KC et al (2011) Magnetic resonance imaging with k-means clustering objectively measures whole muscle volume compartments in sarcopenia/cancer cachexia. Clin Nutr 30:106–111
17. Nguyen HT, Jia G, Shah ZK, Pohar K, Mortazavi A, Zynger DL, Wei L, Yang X, Clark D, Knopp MV (2015) Prediction of chemotherapeutic response in bladder cancer using K-means clustering of dynamic contrast-enhanced (DCE)-MRI pharmacokinetic parameters. J Magn Reson Imaging 41:1374–1382
18. Srinivasan A, Galban CJ, Johnson TD, Chenevert TL, Ross BD, Mukherji SK (2010) Utility of the k-means clustering algorithm in differentiating apparent diffusion coefficient values of benign and malignant neck pathologies. AJNR Am J Neuroradiol 31:736–740
19. Abou-El-Ghar ME, El-Assmy A, Refaie HF, El-Diasty T (2009) Bladder cancer: diagnosis with diffusion-weighted MR imaging in patients with gross hematuria. Radiology 251:415–421
20. Nguyen HT, Pohar KS, Jia G, Shah ZK, Mortazavi A, Zynger DL et al (2014) Improving bladder cancer imaging using 3-T functional dynamic contrast-enhanced magnetic resonance imaging. Investig Radiol 49:390–395
21. Daggulli M, Onur MR, Firdolas F, Onur R, Kocakoc E, Orhan I (2011) Role of diffusion MRI and apparent diffusion coefficient measurement in the diagnosis, staging and pathological classification of bladder tumors. Urol Int 87:346–352
22. El-Assmy A, Abou-El-Ghar ME, Mosbah A, El-Nahas AR, Refaie HF, Hekal IA et al (2009) Bladder tumour staging: comparison of diffusion- and T2-weighted MR imaging. Eur Radiol 19:1575–1581
23. Kilickesmez O, Cimilli T, Inci E, Kayhan A, Bayramoglu S, Tasdelen N et al (2009) Diffusion-weighted MRI of urinary bladder and prostate cancers. Diagn Interv Radiol 15:104–110
24. Kobayashi S, Koga F, Kajino K, Yoshita S, Ishii C, Tanaka H et al (2014) Apparent diffusion coefficient value reflects invasive and proliferative potential of bladder cancer. J Magn Reson Imaging: JMRI 39:172–178
25. Kobayashi S, Koga F, Yoshida S, Masuda H, Ishii C, Tanaka H et al (2011) Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness. Eur Radiol 21:2178–2186
26. Matsuki M, Inada Y, Tatsugami F, Tanikake M, Narabayashi I, Katsuoka Y (2007) Diffusion-weighted MR imaging for urinary bladder carcinoma: initial results. Eur Radiol 17:201–204
27. Takeuchi M, Sasaki S, Ito M, Okada S, Takahashi S, Kawai T et al (2009) Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade. Radiology 251:112–121
28. Suo ST, Chen XX, Fan Y, Wu LM, Yao QY, Cao MQ et al (2014) Histogram analysis of apparent diffusion coefficient at 3.0 T in urinary bladder lesions: correlation with pathologic findings. Acad Radiol 21:1027–1034